INS and Hyperglycemia: The resulting chronic ER stress and impaired insulin secretion contribute to the clinical manifestations of MODY10, which range from neonatal diabetes (severe mutations like R6C) to adult-onset hyperglycemia (milder variants like G32S) [33].